Not logged in.png)
Share.png)
SaveShare Save Share Save Intrinsic STING of CD8+T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects
Xu, Qiuli; Hua, Xin; Li, Bingbing; Jiang, Bei; Jin, Jiajia; Wu, Ranpu; Gu, Yanli; Xu, Hao; Cheng, Qinpei; Zhu, Suhua; Zhang, Fang; Lv, Tangfeng; Song, Yong Share Save LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancerLv, Liting; Miao, Qing; Zhan, Sutong; Chen, Peilin; Liu, Wei; Lv, Jiawen; Yan, Wenjie; Wang, Dong; Liu, Hongbing; Yin, Jie; Feng, Jian; Song, Yong; Ye, Mingxiang; Lv, Tangfeng Share Save Targeted Initiation of Trained Immunity in Tumor-Associated Macrophages with Membrane-Camouflaged Bacillus Calmette-Guerin for Lung Carcinoma ImmunotherapyZhang, Libo; Xiao, Ziyuan; Zhang, Dexin; Yang, Lixin; Yuan, Ziyang; Wang, Guodong; Rui, Xue; Fu, Qiang; Song, Yong; Ren, Ke; Qiao, Haishi Share Save Tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: final analysis of the randomized, phase III RATIONALE-307 trialWang, J.; Lu, S.; Yu, X.; Hu, Y.; Zhao, J.; Sun, M.; Yu, Y.; Hu, C.; Yang, K.; Song, Y.; Lin, X.; Liang, L.; Leaw, S.; Zheng, W. Share Save Lymph nodes rather than pleural metabolic activity in 18F-FDG PET/CT correlates with malignant pleural effusion recurrence in advanced non-small cell lung cancerJiang, Yuxin; Liu, Tao; Xu, Ke; Cheng, Qinpei; Lu, Wanjun; Xie, Jingyuan; Chen, Mo; Li, Yu; Du, Yanjun; Liang, Shuo; Song, Yong; Wu, Jiang; Lv, Tangfeng; Zhan, Ping Share Save Share Save STING mediates LPS-induced acute lung injury by regulating ferroptosisGu, Yanli; Lv, Liting; Jin, Jiajia; Hua, Xin; Xu, Qiuli; Wu, Ranpu; Zhu, Suhua; Liu, Xin; Lv, Tangfeng; Song, Yong; Zhang, Fang Share Save Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II studyZheng, Jing; Wang, Tao; Yang, Yunpeng; Huang, Jie; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang; Guo, Yubiao; Zhou, Chengzhi; Ma, Kewei; Fang, Jian; Feng, Weineng; Liu, Yunpeng; Zheng, Zhendong; Li, Gaofeng; Wang, Huijie; Cang, Shundong; Wu, Ning; Song, Wei; Liu, Xiaoqing; Zhao, Shijun; Ding, Lieming; Selvaggi, Giovanni; Wang, Yang; Xiao, Shanshan; Wang, Qian; Shen, Zhilin; Zhou, Jianya; Zhou, Jianying; Zhang, Li Share Save Share Save Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)Duan, Jianchun; Fang, Wenfeng; Xu, Hairong; Wang, Jinliang; Chen, Yuan; Ding, Yi; Dong, Xiaorong; Fan, Yun; Gao, Beili; Hu, Jie; Huang, Yan; Huang, Cheng; Huang, Dingzhi; Liang, Wenhua; Lin, Lizhu; Liu, Hui; Ma, Zhiyong; Shi, Meiqi; Song, Yong; Tang, Chuanhao; Wang, Jialei; Wang, Lifeng; Wang, Yongfeng; Wang, Zhehai; Yang, Nong; Yao, Yu; Yu, Yan; Yu, Qitao; Zhang, Hongmei; Zhao, Jun; Zhao, Mingfang; Zhu, Zhengfei; Niu, Xiaohui; Zhang, Li; Wang, Jie Share Save Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysisLi, Huijuan; Han, Hedong; Li, Chuling; Wu, Ranpu; Wang, Zhaofeng; Wang, Yimin; Zhan, Ping; Lv, Tangfeng; Zhang, Fang; Song, Yong; Liu, Hongbing Share Save Preliminary results of phase II KUNPENG study of vebreltinib in patients (Pts) with advanced NSCLC harboring c-MET alterationsYang, J-J.; Zhang, Y.; Wu, L.; Hu, J.; Wang, Z-H.; Chen, J-H.; Fan, Y.; Lin, G.; Wang, Q-M.; Yao, Y.; Zhao, J.; Chen, Y.; Fang, J.; Song, Y.; Zhang, W.; Cheng, Y.; Guo, R-H.; Li, X-Y.; Li, A-N.; Wu, Y-L. Share Save Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinomaXu, Ke; Wu, Xiaodi; Chen, Lu; Xie, Jingyuan; Hua, Xin; Chen, Mo; Jiang, Yuxin; Liu, Hongbing; Zhang, Fang; Lv, Tangfeng; Song, Yong; Zhan, Ping Share Save Share Save Share Save A phase II study on Mefatinib as first-line treatment of patients with advanced non-small-cell lung cancer harboring uncommon EGFR mutationsWang, Pingli; Cao, Liming; Tian, Panwen; Ren, Shengxiang; Miao, Liyun; Zhou, Chengzhi; Fan, Yun; Li, Yuping; Lv, Dongqing; Zhao, Xin; Yang, Mei; Zhu, Chaonan; Yu, Bing; Xu, June; Song, Yong; Wang, Kai Share Save Mitochondria-Targeting Pyroptosis Amplifier of Lonidamine-Modified Black Phosphorus Nanosheets for Glioblastoma TreatmentsYe, Youqing; Ren, Ke; Dong, Yuqin; Yang, Lixin; Zhang, Dexin; Yuan, Ziyang; Ma, Ningyi; Song, Yong; Huang, Xin; Qiao, Haishi Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
